Indegene Share Price

Overview
Recos
News
Analysis
Financials
Forecast
Technicals
Peers
Shareholdings
MF
F&O
Corp Actions
About

Indegene Share Price

509.402.65 (0.53%)

Live
As On: 12 Jun, 2026, 11:04 AM IST
As On: 12 Jun, 2026, 11:04 AM IST

Sector: Pharmaceuticals
Industry: Pharma - Indian

1D
1W
1M
3M
6M
1Y
5Y

Loading...

Try ETMarkets GPTNEW

Open	511.60
High	516.10
Low	508.05
Prev Close	506.75
Volume	47,396
VWAP(₹)	511.07

Key Metrics

PE Ratio(x)	30.55
EPS - TTM(₹)	16.65
MCap(₹ Cr.)	12,313.67
MCap Rank	41
PB Ratio(x)	3.98
Div Yield(%)	-
Face Value(₹)	2.00
52W High(₹)	620.20
52W Low(₹)	414.00
MCap/Sales	2.98
Beta(1 Month)	-
BV/Share(₹)	130.29

Indegene share price insights

Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 21.58% outperformed its 3 year CAGR of 14.7%. (Source: Consolidated Financials)
Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 62.6% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)
Indegene Share Price Update
Indegene Ltd. share price moved up by 0.53% from its previous close of Rs 506.75. Indegene Ltd. stock last traded price is 509.40
Share Price Value
Today/Current/Last 509.40509.15
Previous Day 506.75507.85

Found Insights useful?

Indegene Share Price Returns

1 Day	0.53%
1 Month	-3.67%
3 Months	14.87%
1 Year	-14.94%
3 Years	N.A.
5 Years	N.A.

Indegene Share Recommendations

Mean recosCurrent

BUY

6 Analysts

Strong
SellSellHoldBuyStrong
Buy

Analyst Trends

Ratings	Current	1W Ago	1M Ago	3M Ago
Strong Buy	2	2	2	2
Buy	2	2	2	1
Hold	2	2	2	3
Sell	-	-	-	-
Strong Sell	-	-	-	-
# Analysts	6	6	6	6

View all Stock Recommendations

News & Analysis

View all Indegene Share News & Announcements

Financials

	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Income	961.50	823.90	782.90	781.20	758.10
Total Income Growth (%)	16.70	5.24	0.22	3.05	7.05
Total Expenses	822.20	687.00	627.10	628.80	608.60
Total Expenses Growth (%)	19.68	9.55	-0.27	3.32	4.91
EBIT	139.30	136.90	155.80	152.40	149.50
EBIT Growth (%)	1.75	-12.13	2.23	1.94	16.71
Profit after Tax (PAT)	102.90	102.10	116.40	117.60	109.70
PAT Growth (%)	0.78	-12.29	-1.02	7.20	19.63
EBIT Margin (%)	14.49	16.62	19.90	19.51	19.72
Net Profit Margin (%)	10.70	12.39	14.87	15.05	14.47
Basic EPS (₹)	4.29	4.26	4.86	4.91	4.59

	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Income	312.70	324.20	287.70	301.90	309.00
Total Income Growth (%)	-3.55	12.69	-4.70	-2.30	1.61
Total Expenses	261.90	244.70	226.20	234.00	241.30
Total Expenses Growth (%)	7.03	8.18	-3.33	-3.03	-0.08
EBIT	50.80	79.50	61.50	67.90	67.70
EBIT Growth (%)	-36.10	29.27	-9.43	0.30	8.15
Profit after Tax (PAT)	34.80	59.90	45.10	54.20	49.90
PAT Growth (%)	-41.90	32.82	-16.79	8.62	11.38
EBIT Margin (%)	16.25	24.52	21.38	22.49	21.91
Net Profit Margin (%)	11.13	18.48	15.68	17.95	16.15
Basic EPS (₹)	1.45	2.50	1.88	2.26	2.09

	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	2,946.50	2,665.90	2,364.10	1,690.50
Total Revenue Growth (%)	10.53	12.77	39.85	69.57
Total Expenses	2,407.20	2,209.70	2,001.05	1,417.10
Total Expenses Growth (%)	8.94	10.43	41.21	84.46
Profit after Tax (PAT)	406.70	336.70	266.10	164.76
PAT Growth (%)	20.79	26.53	61.51	10.28
Operating Profit Margin (%)	19.76	19.52	17.10	16.78
Net Profit Margin (%)	14.32	13.00	11.53	9.89
Basic EPS (₹)	17.15	15.19	12.03	7.50

	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	1,184.00	1,095.90	1,042.50	864.50	535.10
Total Revenue Growth (%)	8.04	5.12	20.59	61.56	53.02
Total Expenses	945.50	915.30	865.90	694.60	381.70
Total Expenses Growth (%)	3.30	5.71	24.66	81.98	43.82
Profit after Tax (PAT)	181.30	137.90	130.20	132.70	133.40
PAT Growth (%)	31.47	5.91	-1.88	-0.52	320.82
Operating Profit Margin (%)	22.37	17.90	18.19	20.66	30.70
Net Profit Margin (%)	16.57	13.18	12.94	15.85	26.10
Basic EPS (₹)	7.64	6.22	5.89	6.05	850.37

All figures in Rs Cr, unless mentioned otherwise

Insights

Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 21.58% outperformed its 3 year CAGR of 14.7%. (Source: Consolidated Financials)
Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 62.6% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)

Annual	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	3,325.90	2,545.60	2,203.87	1,353.47
Total Assets Growth (%)	30.65	15.51	62.83	127.08
Total Liabilities	710.30	1,116.50	1,140.14	589.57
Total Liabilities Growth (%)	-36.38	-2.07	93.39	124.21
Total Equity	2,615.60	1,429.10	1,063.72	763.90
Total Equity Growth (%)	83.02	34.35	39.25	129.34
Current Ratio (x)	4.48	2.93	2.96	2.57
Total Debt to Equity (x)	0.00	0.28	0.37	0.02
Contingent Liabilities	-	-	-	-

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Assets	2,149.70	1,220.30	1,037.70	850.10	564.60
Total Assets Growth (%)	76.16	17.60	22.07	50.57	30.97
Total Liabilities	261.50	266.50	242.40	200.10	122.40
Total Liabilities Growth (%)	-1.88	9.94	21.14	63.48	2.94
Total Equity	1,888.20	953.80	795.30	650.00	442.20
Total Equity Growth (%)	97.97	19.93	22.35	46.99	-
Current Ratio (x)	6.43	3.79	4.15	3.80	4.23
Total Debt to Equity (x)	0.00	0.00	0.00	0.00	0.00
Contingent Liabilities	-	0.70	10.10	0.50	0.50

All figures in Rs Cr, unless mentioned otherwise

Annual	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	441.90	507.70	130.22	297.04
Net Cash used in Investing Activities	-682.70	-327.20	-893.35	-160.21
Net Cash flow from Financing Activities	287.50	-66.20	333.09	233.48
Net Cash Flow	52.40	115.00	-432.69	372.92
Closing Cash & Cash Equivalent	241.00	188.60	73.59	506.28
Closing Cash & Cash Equivalent Growth (%)	27.78	156.30	-85.47	279.63
Total Debt/ CFO (x)	0.00	0.79	3.03	0.06

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash flow from Operating Activities	129.00	176.20	81.90	38.20	54.60
Net Cash used in Investing Activities	-824.70	-187.70	-47.90	-266.70	-34.00
Net Cash flow from Financing Activities	717.30	-15.80	-16.90	244.90	-35.50
Net Cash Flow	22.00	-28.60	14.00	16.20	-17.90
Closing Cash & Cash Equivalent	35.20	13.20	41.80	27.80	11.60
Closing Cash & Cash Equivalent Growth (%)	166.67	-68.42	50.36	139.66	-60.68
Total Debt/ CFO (x)	0.00	0.00	0.00	0.00	0.00

All figures in Rs Cr, unless mentioned otherwise

Insights

Decrease in Cash from Investing
Company has used Rs 512.4 cr for investing activities which is an YoY decrease of 24.95%. (Source: Consolidated Financials)

Annual	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	15.55	23.56	25.01	21.56
Return on Capital Employed (%)	20.32	26.13	22.99	30.59
Return on Assets (%)	12.22	13.22	12.07	12.17
Interest Coverage Ratio (x)	29.16	11.78	14.50	52.46
Asset Turnover Ratio (x)	0.97	1.09	1.30	1.71
Price to Earnings (x)	34.13	-	-	-
Price to Book (x)	5.30	-	-	-
EV/EBITDA (x)	21.00	-	-	-
EBITDA Margin (%)	22.59	22.46	19.69	18.79

Annual	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Return on Equity (%)	9.60	14.45	16.37	20.41	30.16
Return on Capital Employed (%)	12.48	18.31	21.07	24.37	33.55
Return on Assets (%)	8.43	11.30	12.54	15.60	23.62
Interest Coverage Ratio (x)	43.69	33.08	33.55	65.50	49.86
Asset Turnover Ratio (x)	0.65	0.93	1.07	1.18	1.03
Price to Earnings (x)	76.92	-	-	-	-
Price to Book (x)	7.34	-	-	-	-
EV/EBITDA (x)	50.52	-	-	-	-
EBITDA Margin (%)	24.77	20.87	21.34	23.48	34.14

Found Financials useful?

Share Price Forecast

Exclusively for ETPrime

REVENUE
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
READ FOR FREE ON APP
EARNINGS
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
READ FOR FREE ON APP
PRICE
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
READ FOR FREE ON APP

Technicals

Buy/Sell Signals
No Data Available
Price Analysis
44%
Positive Movement
since 1st Jan 2005
on basis
56%
Negative Movement
since 1st Jan 2005
on basis
Exclude
Global Meltdown1st Jan 2008 to 10th Nov 2008
Covid Crisis1st Feb 2020 to 31st Mar 2020
Pivot Levels
R1 518.70 Pivot
511.65
S1 499.70
R2 530.65 S2 492.65
R3 549.65 S3 473.65
Average True Range
5 Days 14 Days 28 Days
16.71 16.41 16.56

Peer Comparison

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Indegene	30.55	3.90	12.77	15.97	8.68	14.70	16.08	11.42	16.72	2.41	0.00	0.00
Add More stocks of your interest to compare.

Annual Ratios (%)

Choose from Peers

Choose from Stocks

Stock Performance
- CHART
- TABLE
- 1D
- 1W
- 1M
- 3M
- 6M
- 1Y
- 5Y
- Choose from Peers
  Choose from Stocks
- There’s no suggested peer for this stock.
NAME 1D 1W 1M 3M 1Y 3Y 5Y
Indegene Stock Performance 0.49 -1.28 4.50 4.98 -15.19 0.00 0.00
Add More stocks of your interest to compare.
All values in %
Choose from Peers
Choose from Stocks

Shareholding Pattern

Total Shareholdings
Category No. of Shares Percentage % Change QoQ
FII 2,47,29,637 10.27 % -1.21
DII 1,99,79,325 8.29 % 0.22
MF 1,13,18,585 4.70 % 0.29
Others 19,61,92,392 81.44 % 0.97
QoQ Change
Category Mar 2026 Dec 2025 Sep 2025 Jun 2025
Promoters 0.00 0.00 0.00 0.00
Pledge 0.00 0.00 0.00 0.00
FII 10.27 11.48 11.30 10.04
DII 8.29 8.06 6.94 7.19
Mutual Funds 4.70 4.40 3.07 3.37
Others 81.44 80.46 81.75 82.77

Mutual Funds Ownership

MF Ownership as on 30 April 2026

SBI Innovative Opportunities Direct-G
Equity: Thematic-Innovation
- 104.39
  Amount Invested (in Cr.)
- 2.09%
  % of AUM
- 0.00
  % Change (MoM basis)
ICICI Pru Technology Direct-G
Equity: Sectoral-Technology
- 93.20
  Amount Invested (in Cr.)
- 0.71322812%
  % of AUM
- 0.00
  % Change (MoM basis)
Sundaram Mid Cap Direct-G
Equity: Mid Cap
4
- 78.31
  Amount Invested (in Cr.)
- 0.585399%
  % of AUM
- 0.00
  % Change (MoM basis)

View all Mutual Fund Schemes

Indegene Top Searches

Corporate Actions

Recent
Board Meeting
Quarterly Results & ESOP
Jan 22, 2026
General Meeting
-
Dec 22, 2025
Board Meeting
Quarterly Results
Oct 23, 2025

Announced on	Meeting on
Jan 22, 2026	Jan 29, 2026
Quarterly Results & ESOP
Oct 23, 2025	Oct 30, 2025
Quarterly Results
Jul 24, 2025	Jul 31, 2025
Quarterly Results
Apr 21, 2025	Apr 28, 2025
Audited Results & Final Dividend
Jan 27, 2025	Jan 30, 2025
Quarterly Results & Others

Dividends
Announced on Ex-Date Dividend%
Apr 28, 2025 Jun 13, 2025 100%
Bonus
No Data Available
Splits
No Data Available
Rights
No Data Available
AGM/EGM Meetings
Announced on Meeting on
Dec 22, 2025 Jan 28, 2026
-
Jul 11, 2025 Aug 14, 2025
-
May 30, 2025 Jun 26, 2025
-
Mar 17, 2025 Apr 22, 2025
-
Aug 08, 2024 -
Book closure from Aug 30, 2024 to Sep 6, 2024

About Indegene

Indegene Ltd., incorporated in the year 1998, is a Small Cap company (having a market cap of Rs 12,207.68 Crore) operating in Pharmaceuticals sector.

Indegene Ltd. key Products/Revenue Segments include Services Rendered for the year ending 31-Mar-2025.

For the quarter ended 31-03-2026, the company has reported a Consolidated Total Income of Rs 1,014.20 Crore, up 5.48 % from last quarter Total Income of Rs 961.50 Crore and up 29.83 % from last year same quarter Total Income of Rs 781.20 Crore. Company has reported net profit after tax of Rs 79.70 Crore in latest quarter.

The company’s top management includes Mr.Manish Gupta, Dr.Sanjay Suresh Parikh, Mr.Mark Francis Dzialga, Mr.Neeraj Bharadwaj, Dr.Rajesh Bhaskaran Nair, Dr.Ashish Gupta, Dr.Georgia Nikolakopoulou Papathomas, Mr.Jairaj Manohar Purandare, Mr.Krishnamurthy Venugopala Tenneti, Mr.Parvin Udhyavara Bhadya Rao, Mr.Suhas Prabhu, Mr.Srishti Ramesh Kaushik. Company has B S R & Co. LLP as its auditors. As on 31-03-2026, the company has a total of 24.09 Crore shares outstanding.

Indegene Share Price Today is Rs. 509.40. On previous day, the Indegene Share Price (NSE) closed at Rs. 518.5, featuring among the most traded securities on the National Stock Exchange.

Shareholdings:
As of 31st Mar, 2026, the promoter held 0.0% of the stake in Indegene shares, out of which 0.0% was pledged. On the same date, foreign institutional investors' (FII) holdings of Indegene stocks was 10.27% as compared to 11.48% in Dec 2025 with decrease of 1.21%. The domestic institutional investors (DII) holdings on 31st Mar, 2026 was 8.29% as compared to 8.06% in Dec 2025 with increase of 0.23%. Out of the total DII holdings in Indegene shares 4.7% was held by mutual funds. The rest including public held is 0.0%. Indegene stock price is reflected on both the exchanges - BSE and NSE.

Dividend, Bonus & Split Information:
Indegene Dividend: Ever since 1998, Indegene dividends has been paid out around 2 times. As on 12 Jun, 2026, 11:04 AM IST, The overall dividend yield for Indegene stands at 0.0%. The last dividend paid was on June 13, 2025 (Rs. 2.0). The Earnings Per Share (EPS) for quarter ending 31st Mar 2026 is Rs. 16.65.

Indegene Bonus: The most recent bonus issue had been in year null around 0 years ago at 0 : 0 ratio. The first bonus issue was announced in null.

Stock Forecast:
After showing 1014.2 Cr. of sales and 5.48% of quarterly net profit, there have been multiple ups and downs in the Indegene stock prices in the past few weeks. For example, Indegene stock price on 4th of June 2026 was around Rs. 518.05. Indegene share price now stands at an average of Rs. 509.40. Judging by last week's performance, stock is in up trend.

Indegene has a median target price of Rs. 593.4 in 12 months by 5 analysts. They have provided a high estimate of Rs. 705.0 and low estimate of Rs. 480.0 for Indegene share.

Historical Prices and Performance:
Indegene, incorporated in 1998 is a Mid Cap company (with a market cap of Rs. 12207.68) operating in Pharmaceuticals sector.
The Return of Equity (ROE) in last five financial years given by Indegene stock was 12.77%, 15.55%, 23.56%, 25.01% and 21.56% respectively.
The Indegene share gave a 3 year return of 0.0% as compared to Nifty 50 which gave a return of 0.0%.
Indegene announced 100.0% final dividend on June 13, 2025.

Key Metrics:
PE Ratio of Indegene is 30.44
Prices/Sales Ratio of Indegene is 2.98
Price/Book Ratio of Indegene is 3.89

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. For Indegene, major competitors and peers include Aditya Infotech Ltd., Belrise Industries Ltd., Urban Company Ltd. and Travel Food Services Ltd.. As of Dec 2025, the dividend yield of Indegene stands at 0.0% while Aditya Infotech Ltd., Belrise Industries Ltd., Urban Company Ltd. and Travel Food Services Ltd. stand at 0.05%, 0.0%, 0.0% and 0.84% respectively. The PE ratio and PB Ratio of the company are among its competitors stand at 30.44 and 3.89 respectively.

Leadership of Indegene :
Srishti Ramesh Kaushik is Co. Secretary & Compl. Officer
Suhas Prabhu is Chief Financial Officer
Sanjay Suresh Parikh is Executive Vice President
Manish Gupta is Chairman & CEO
Sanjay Suresh Parikh is Executive Director
Rajesh Bhaskaran Nair is Non Executive Director
Krishnamurthy Venugopala Tenneti is Ind. Non-Executive Director
Ashish Gupta is Ind. Non-Executive Director
Jairaj Manohar Purandare is Ind. Non-Executive Director
Parvin Udhyavara Bhadya Rao is Ind. Non-Executive Director
Georgia Nikolakopoulou Papathomas is Ind. Non-Executive Director
Neeraj Bharadwaj is Non Exe. & Nominee Director
Mark Francis Dzialga is Non Exe. & Nominee Director

Show More

Industry

Pharma - Indian

Key Indices Listed On

Nifty 500, BSE 500, BSE SmallCap, BSE Healthcare, BSE 400 MidSmallCap Index

Address

Aspen Block G4, 3rd Floor,Manyata Embassy Business Park,Bengaluru, Karnataka - 560045

Contact

compliance.officer@indegene.com

http://www.indegene.com

Executive Leadership

MG

Manish Gupta

Chairman & CEO

SS

Sanjay Suresh Parikh

Executive Director

MF

Mark Francis Dzialga

Non Exe. & Nominee Director

NB

Neeraj Bharadwaj

Non Exe. & Nominee Director

Show More

Auditors

B S R & Co. LLP

FAQs about Indegene share

1. What's Indegene share price today and what are Indegene share returns ?
Indegene share price is Rs 509.40 as on 12 Jun, 2026, 11:04 AM IST. Indegene share price is up by 0.53% based on previous share price of Rs. 518.5.
2. What is the PE & PB ratio of Indegene?
The PE ratio of Indegene stands at 30.44, while the PB ratio is 4.64.
3. What is the market cap of Indegene?
Within the Pharmaceuticals sector, Indegene stock has a market cap rank of 41. Indegene has a market cap of Rs 12,313.67 Cr.
4. What is Indegene's 52 week high / low?
Indegene share price saw a 52 week high of Rs 620.20 and 52 week low of Rs 414.00.
5. What are the returns for Indegene share?
Return Performance of Indegene Shares:
- 1 Week: Indegene share price moved down by 2.60%

Top Gainers

As on 11:04 AM | 12 Jun 2026

Authum Investment

515.80

55.85 (12.15%)

Netweb Technologies

4,495.70

304.31 (7.27%)

Aavas Financiers

1,424.50

96.30 (7.26%)

75.53

5.05 (7.17%)

Data Patterns (India)

4,468.80

263.81 (6.28%)

Top Losers

As on 11:04 AM | 12 Jun 2026

245.00

-7.60 (-3.01%)

417.70

-11.66 (-2.72%)

OneSource Specialty

1,623.20

-28.21 (-1.71%)

1,367.70

-21.80 (-1.57%)

1,455.90

-22.60 (-1.53%)

Equity Quick Links

Top Gainers
Top Losers
Hourly gainers
Hourly losers
Sensex
Nifty
NSE
BSE

Midcap stocks
Smallcap stocks
Largecap stocks
Sensex
Nifty
NSE
BSE
MCX Live

More from Markets

IPO
Stock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list

Trending in Markets

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.